MRF Breakthrough Consortium Steering Committee

The Melanoma Research Foundation Breakthrough Consortium’s (MRFBC) strategy and efforts are overseen by a Steering Committee comprised of members of the Consortium, MRF Board of Directors and melanoma patient advocates.

Co-Chairs

Richard D. Carvajal, MD – Northwell Health, New York City, NY

Tara C. Mitchell, MD – Penn Medicine, Pennsylvania, PA

Ryan J. Sullivan, MD – Dana-Farber/Harvard Cancer Center, Boston, MA

 

Members

Elizabeth I. Buchbinder, MD – Dana-Farber/Harvard Cancer Center, Boston, MA

Zeynep Eroglu, MD – Moffit Cancer Center, Tampa, FL

Douglas B. Johnson, MD, MDCI – Vanderbilt University Medical Center, Nashville, TN

Geoffrey T. Gibney, MD – Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC

Michael A. Postow, MD – Memorial Sloan Kettering Cancer Center, New York City, NY

Hussein A. Tawbi, MD, PhD – University of Texas, MD Anderson Cancer Center, Houston, TX

Keith T. Flaherty, MD – Dana-Farber/Harvard Cancer Center, Boston, MA

Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC